相关实验视频
Updated: Sep 9, 2025

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
双人对抗. 在类风湿性关节炎中单独的抗Ro抗体阳性
Yan Ma1, Chaoyu Gu1, Qianqian Li1
1Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
双抗Ro52/TRIM21和抗Ro60/SSA抗体在类风湿性关节炎 (RA) 中显示出较高的疾病活性和全身并发症. 单独的抗Ro60阳性表明RA表型较轻,指导个性化治疗.
科学领域:
- 关节病学
- 免疫学
- 临床医学
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,其特征是关节炎和潜在的全身症状.
- 在自身免疫疾病中经常检测到抗Ro52/TRIM21和抗Ro60/SSA抗体,但它们在RA病变和临床结果中的特定作用需要进一步阐明.
研究的目的:
- 研究抗Ro52/TRIM21和抗Ro60/SSA抗体在类风湿性关节炎 (RA) 中的临床和免疫意义.
- 评估双抗体阳性与RA疾病严重程度,全身并发症和治疗耐药性的关联.
主要方法:
- 对670名RA患者进行了队列研究.
- 根据抗Ro52和抗Ro60抗体状态,患者被分为四组:Ro52+/ Ro60+,Ro52+/ Ro60-,Ro52-/ Ro60+和Ro52-/ Ro60-.
- 临床特征,疾病活性评分 (DAS28-ESR,DAS28-CRP),全身并发症和治疗反应进行了比较,多变量逻辑回归确定了难以治疗的RA (D2T-RA) 的预测因素.
主要成果:
- 与抗体阴性患者相比,双抗Ro52+/ Ro60+阳性与显著更高的疾病活性 (DAS28- ESR: 4. 97对4. 39) 和更差的功能状态 (HAQ- DI: 0. 88对0. 63) 相关.
- 在双阳性患者中观察到系统性并发症的增加,包括间歇性肺病 (OR=4. 14) 和血液干扰 (OR=2. 50).
- 双抗体阳性独立预测了难以治疗的RA (D2T-RA) 的风险增加 (OR=4. 05).
结论:
- 抗Ro抗体亚型有效地识别出不同的临床和免疫性RA亚组.
- 与双抗体阳性患者相比,单独抗Ro60阳性患者的临床状况较为不严重.
- 特定的抗Ro抗体概况对于指导个人化临床管理和治疗决策至关重要.
更多相关视频
10:05Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
Published on: January 17, 2018
10:16Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
Published on: September 15, 2016
相关概念视频
Rh Blood Group
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Cross-reactivity
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...